Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hokuyaku Takeyama HoldingsSSE:3055 +1.43%71 Buyback Yield % is 2.13 as of Jul. 24, 2026, which is 10% above its 10-year median of 1.94. GuruFocus rates SSE:3055 with a GF Score™ of 71/100 and a GF Value™ of 円958.19 (Fairly Valued). The stock has 4 warning signs investors should review. Among 40 Medical Distribution companies, Hokuyaku Takeyama Holdings ranks better than 70% on this metric.
Buyback yield is the net repurchase of shares outstanding over the market capital of the company. It is a measure of shareholder return.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SSE:3055 vs MCK, CAH, COR: Buyback Yield % Comparison
For the Medical Distribution subindustry, Hokuyaku Takeyama Holdings's Buyback Yield %, along with its competitors' market caps and Buyback Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hokuyaku Takeyama Holdings Buyback Yield % vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, Hokuyaku Takeyama Holdings's Buyback Yield % distribution charts can be found below:
* The bar in red indicates where Hokuyaku Takeyama Holdings's Buyback Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hokuyaku Takeyama Holdings (SSE:3055) has a Buyback Yield % of 2.13 as of Jul. 24, 2026. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Hokuyaku Takeyama Holdings and its competitors. This is 10% above median its historical median of 1.94. Over the past decade, Hokuyaku Takeyama Holdings' Buyback Yield % has ranged from 0.22 to 3.49. According to the industry distribution chart, Hokuyaku Takeyama Holdings ranks #12 out of 40 companies in the Medical Distribution industry, placing it in the top 30%.
Is Hokuyaku Takeyama Holdings' Buyback Yield % too high?
Hokuyaku Takeyama Holdings' current Buyback Yield % of 2.13 is 10% above median its 10-year median of 1.94. Over the past 10 years, this metric has ranged from a low of 0.22 to a high of 3.49. Based on the distribution chart, Hokuyaku Takeyama Holdings ranks #12 out of 40 companies in the Medical Distribution industry, which is above the industry midpoint. Overall, Hokuyaku Takeyama Holdings has a GF Score™ of 71/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Hokuyaku Takeyama Holdings' Buyback Yield % compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, Hokuyaku Takeyama Holdings ranks #12 out of 40 companies for Buyback Yield %. This puts Hokuyaku Takeyama Holdings in the upper half of its industry. Historically, Hokuyaku Takeyama Holdings' own Buyback Yield % has ranged from 0.22 to 3.49 over the past decade. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Buyback Yield % for a Medical Distribution company?
A good Buyback Yield % depends on the Medical Distribution industry context. However, Buyback Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Buyback Yield % mean?
A high Buyback Yield % can signal that a stock is expensive relative to its fundamentals. Share buyback yield equals the net issuance of stock divided by market cap. View historical data on Hokuyaku Takeyama Holdings and its competitors. Hokuyaku Takeyama Holdings's current Buyback Yield % is 2.13, which is 10% above median its own 10-year median of 1.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hokuyaku Takeyama Holdings stock overvalued right now?
Based on GuruFocus' analysis, Hokuyaku Takeyama Holdings (SSE:3055) is currently considered Fairly Valued. The stock's GF Value™ is 円958.19, compared to a current price of 円925.00 — trading 3.5% below its estimated fair value. The current Buyback Yield % is 2.13, which is 10% above median its 10-year median of 1.94. Hokuyaku Takeyama Holdings' overall GF Score™ is 71/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Buyback Yield % calculated?
Buyback Yield % is calculated from a company's financial statements. For Hokuyaku Takeyama Holdings (SSE:3055), the current Buyback Yield % is 2.13 as of Jul. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hokuyaku Takeyama Holdings (SSE:3055) Overvalued in 2026?
Based on GuruFocus' analysis, Hokuyaku Takeyama Holdings stock appears to be undervalued.
The current stock price of 円925.00 is trading 3.5% below its estimated GF Value™ of 円958.19.
GuruFocus considers Hokuyaku Takeyama Holdings to be Fairly Valued.
Key valuation signals for SSE:3055:
Buyback Yield %: 2.13 (10% above median its 10-year median of 1.94)
GF Value™: 円958.19 vs. price of 円925.00 (3.5% below fair value)
No single metric tells the full story. See the SSE:3055 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hokuyaku Takeyama Holdings Inc is a medical device wholesaler. The company also distributes ethical drugs and general-purpose medicines. It offers repair services for medical instruments and manages real estate for physics and chemistry instruments.
71GF Score
Get the complete analysis for SSE:3055
Buyback Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SSE:3055 has been successfully added to your 
